Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial

Fang Gao Smith(University Hospitals Birmingham NHS Foundation Trust), Sarah E Lamb(University of Exeter), Duncan Young(University of Oxford), Zahid Khan(Smiths Detection (Canada)), Gavin D. Perkins(University Hospitals Coventry and Warwickshire NHS Trust), William Tunnicliffe(Queen Elizabeth Hospital Birmingham), Simon Gates(Oxford Brookes University), Daniel F. McAuley(Queen's University Belfast)
The Lancet
December 12, 2011
10.1016/s0140-6736(11)61623-1
Cited by 331

Related Papers

Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
|JAMA|2016|5.9k
Interventions for preventing falls in older people living in the community
|Cochrane Database of Systematic Reviews|2012|3.9k
World guidelines for falls prevention and management for older adults: a global initiative
|Age and Ageing|2022|1.5k
Midwife-led continuity models versus other models of care for childbearing women
|Cochrane Database of Systematic Reviews|2013|1.2k
Continuous support for women during childbirth
|Cochrane Database of Systematic Reviews|2012|1.2k